http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007208079-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b0ec13a92fa0e2d978ff903b86a1de1b |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-216 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-216 |
| filingDate | 2007-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_773307759405f278bccbf0593f9e3380 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_281eafc81de1bb0b985136cc60aa19ba |
| publicationDate | 2007-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-2007208079-A1 |
| titleOfInvention | Myriceric acid derivatives for the treatment of cancer, cardiovascular and inflammatory diseases |
| abstract | The present invention relates to the use of certain novel myriceric acid derivatives of the formula: n n n n n n n n n n which are inhibitors of nuclear factor kappa B (NF-κB) and inhibit the activity of the endothelin receptor for use in the treatment of cardiovascular and inflammatory diseases and for cancers susceptible to an NF-κB inhibitor and an endothelin receptor inhibitor. The present invention also relates to compounds and methods useful to inhibit cell proliferation and for the induction of apoptosis. |
| priorityDate | 2006-03-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 272.